TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: GET as measured by the SmartPill System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CTT as measured by the Atmo Motility System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CTT as measured by the SmartPill System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Average global self-care score at discharge from inpatient unit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average global self-care score at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in depressive symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lung Ultrasound Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bridging stent patency at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative assessment of the atherosclerotic burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of high risk plaque features
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Successful pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean absolute error of urine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Dim light melatonin onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Acceptability of the Intervention- Net Promoter Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Measures of regional lung ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Measures of blood volume distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Social Responsiveness Scale Second Edition (SRS-2) total score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of adverse events during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of adverse events during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of DM (Diabetes Mellitus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Attitudes Toward HPV Vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions Toward HPV Vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite cardiovascular, respiratory, and renal sequential organ failure assessment (CRR-SOFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite cardiovascular, respiratory, and renal sequential organ failure assessment (CRR-SOFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Composite cardiovascular, respiratory, and renal sequential organ failure assessment (CRR-SOFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Demand of the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hemoglobin stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum ferritin stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: National Pain Score (NPRs)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PROMIS-29 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: RMDQ questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Detection of pulmonary hypertension (PH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection of patients without pulmonary hypertension (PH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Comparison of AIT performance with current probability criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Surface Electromyography intensity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frontal inclination of ankle change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip abductor strength change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in causal sebum measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Opioid consumption (mean cumulative MME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SECEL (SECEL:HR) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 1-month DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Discontinue Study Treatment Due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Modify or Interrupt Study Treatment Due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Experience at Least One Dose-limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Change of the MATRICS Consensus Cognitive Battery score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of clinical symptoms by Positive And Negative Syndrome Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of clinical symptoms by Clinical Global Impression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leukocytosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Liver abscess
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Liver abscess and intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: AUC of DAG181
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of DAG181
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants who Experience Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Motor function score of Unified Huntington's Disease Rating Scale (UHDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of low-dose [18F]FDG PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The rate of intrapartum cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of approached patients included
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of study assessments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from Baseline in Work Productivity Loss
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from Baseline in the Severity of Insomnia Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in score of the Appraisal of Diabetes Scale (ADS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Measure Yourself Medical Outcome Profile (MYMOP)2 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in the EQ-5D-5L tool score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Peripheral block success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CEA blood test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: IGRA blood test results with CEA protein antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IGRA blood test results with TB antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in tibial intracortical blood flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sperm oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Changes in the Symptoms of Insomnia after Brief Behavioral Therapy for Insomnia (BBTI) as Measured by Insomnia Severity Index (ISI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Sleep Efficiency after Brief Behavioral Therapy for Insomnia (BBTI) as Measured by Actigraphy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Substance Used Outcome as Measured by Treatment Retention [days]
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 35% reduction in spleen volume (SVR35) at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower opioid use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of successful cervical fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percent change in Spherical equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in maximum pupil diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in pupil constriction percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility as measured by enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of nurse managed adherence strategy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usefulness of contact with nurse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Failure rates of brackets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-related serious adverse event (SAE) rate
Endpoint domain: Adverse events/effects
Primary endpoint: Rating of Absorption in music
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Optimization of the IOL constant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of Intervention Measure (AIM) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intervention Appropriateness Measure (IAM) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of Intervention Measure (FIM) Score
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: perioperative pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of colorectal neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cognitive/Behavioral Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Task Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scored Patient-Generated Subjective Global Assessment score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DMSM score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Plasma concentrations of LEAP2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental wellbeing measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in executive function as measured by Trails A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in executive function as measured by Trails B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in executive function as measured by the Controlled Oral Word Association Test (COWAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in working memory as measured by the Hopkins Verbal Learning Test-Revised (HVLT-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Utility measured using the Wheelchair Outcome Measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total time standing - Study Wheelchair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total time standing - Existing Standing Device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with infusion associated reactions (IAR)
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative Total of New Antipsychotic Pill-days Prescribed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Point-Prevalence Abstinence at End of Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence of any unsolicited systemic adverse events (AEs) reported in the 30 minutes after injection
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of solicited injection site reactions occurring up to 7 days after injection
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of solicited systemic reactions occurring up to 7 days after injection
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of unsolicited AEs reported up to 28 days after injection
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of medically attended AEs (MAAEs) reported up to 28 days after injection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the appearance of fine lines and wrinkles on the face
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in facial skin hydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Parents' self efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parenting practices and parent child relationship
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Parents' well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rates of Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants who strongly agree or agree that the intervention is acceptable
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EEG gamma and theta activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Attempts to Successful Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time for Successful Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Difficulty Level of Intubation as Assessed by Intubation Difficulty Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Correlation of AMH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Severity of DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: Relative Telomere Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pediatric peripheral infiltration scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-emergent ocular adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of treatment-emergent ocular adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Relatedness of treatment-emergent ocular adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of treatment-emergent serious adverse events (TE-SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Activities of Daily Living Scale (ADL) Change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Instrumental Activities of Daily Living (IADL) Change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Colony Forming Unit (CFU) count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Survival with good neurologic outcomes
Endpoint domain: Mortality/survival
Primary endpoint: CPC score of 1 or 2 at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Glutathione concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Interleukin 6 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Ordinal scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Level of self-stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite of recurrent pulmonary embolism, major bleeding, or death
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients showing a >50% reduction in frequency of seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in number of epileptic seizures as documented by patient diaries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: N75-p100 amplitude of FVEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalographic changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concentration of interstitial glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adherence to hepatitis C screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent difference in tracer uptake values between tumor mass and background
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in puff duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross and nett OR time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Radiation dose (DAP[Gycm2])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rating of autonomous system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under curve (0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve (0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects with Dose-Limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with AE, IrAEs, IRRs, SAEs and abnormalities in Lab
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in NSAA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate and Oxygen Saturations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frankl Behaviour Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Modified Houpt Behaviour Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: negative predictive value of a malaria RDT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Ability to achieve adaptive therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Change from Baseline in Colorectal Polyp Burden for all Polyps at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage Change from Baseline in Colorectal Polyp Burden for Polyps >=2 mm at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from tear break up time at week 4 follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change from tear break up time at week 8 follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change from tear break up time at week 12 follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Immunoglobulin A detection in human serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunoglobulin M detection in human serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunoglobulin G detection in human serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Severity of borderline personality symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Female Sexual Function Index (FSFI): orgasm domain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing